Satish Reddy Kallam
About Satish Reddy Kallam
Satish Reddy Kallam has 33 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 21 companies, including Dr. Reddy's Bio-Sciences Limited and Dr.Reddy's Laboratories Ltd. Formerly with 29 companies, such as Zenfold Ventures Llp and Proline Real Estates Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Dr. Reddy's Bio-Sciences Limited
U72200TG2000PLC034765
|
Director | 06 Jul 2003 | 2000 | Active |
Dr.Reddy's Laboratories Ltd
L85195TG1984PLC004507
|
Whole-Time Director | 18 Jan 1993 | 1984 | Active |
Araku Originals Private Limited
U01119MH2008PTC282862
|
Director | 04 Sep 2013 | 2008 | Active |
Aurigene Oncology Limited
U24239KA2001PLC029391
|
Director | 10 Aug 2001 | 2001 | Active |
Kar Therapeutics & Estates Private Limited
U24233TG1995PTC020683
|
Director | 14 Jun 1995 | 1995 | Active |
Satish Reddy Estates Private Limited
U45200TG1995PTC020684
|
Director | 14 May 1996 | 1995 | Active |
Quin Estates Private Limited
U45200TG1995PTC020712
|
Director | 15 Jun 1995 | 1995 | Active |
Cipro Estates Private Limited
U45200TG1995PTC020713
|
Director | 15 Jun 1995 | 1995 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Zenfold Ventures Llp
AAO-2259
|
Partner | 14 Mar 2022 | 2019 | Active |
Proline Real Estates Private Limited
U70100AP1996PTC023977
|
Director | 14 Mar 2002 | 1996 | Amalgamated |
Cheminor Investments Ltd
U67120TG1990PLC010931
|
Director | 21 Apr 2010 | 1990 | Active |
Ecologic Technologies Limited
U74900TG2008PLC058294
|
Director | 09 Jul 2009 | 2008 | Strike Off |
Drl Impex Limited
U65990TG1986PLC006695
|
Director | 07 Dec 1994 | 1986 | Active |
Young President's Organisation Hyderabad Chapter
U93000TG2007NPL055534
|
Director | 26 Jul 2012 | 2007 | Active |
Idea2enterprises (India) Private Limited
U72200TG2000PTC034473
|
Director | 12 Dec 2000 | 2000 | Active |
Dr.Reddy's Research Foundation
U73100TG1986GAP006218
|
Director | 01 May 1993 | 1986 | Active |
I-Ven Pharma Capital Limited
U24231KA2005PLC035853
|
Director | 01 Oct 2010 | 2005 | Under Liquidation |
Dr.Reddy's Holdings Limited
U67120TG1994PLC017906
|
Director | 12 Jul 1994 | 1994 | Amalgamated |
Alanine Real Estates Private Limited
U70100TG1996PTC023862
|
Director | 22 Apr 1996 | 1996 | Amalgamated |
Lansa Real Estates Private Limited
U70100TG1996PTC024086
|
Director | 14 Mar 2002 | 1996 | Amalgamated |
Oxo Real Estates Private Limited
U70100TG1996PTC024090
|
Director | 15 May 1996 | 1996 | Amalgamated |
Ibu Real Estates Private Limited
U70100TG1996PTC024098
|
Director | 15 May 1996 | 1996 | Amalgamated |
Meditimes (India) Private Limited
U72200TG1999PTC032168
|
Director | 02 Aug 2000 | 1999 | Strike Off |
Napro Real Estates Private Limited
U70100TG1996PTC024087
|
Director | 14 May 1996 | 1996 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satish Reddy Kallam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satish Reddy Kallam
Satish Reddy Kallam has 33 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 21 companies, including Dr. Reddy's Bio-Sciences Limited and Dr.Reddy's Laboratories Ltd. Formerly with 29 companies, such as Zenfold Ventures Llp and Proline Real Estates Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Satish Reddy Kallam is associated with 21 companies as Director and Whole-Time Director.
Satish Reddy Kallam has expertise in General Business, Technology.
Satish Reddy Kallam has 33 years in corporate governance.